University Hospital Tuebingen: Parkinson Disease trials
The registry lists 10 Parkinson Disease studies with University Hospital Tuebingen as lead sponsor. 3 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 1No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Dual-task Cognitive-motor Telerehabilitation in Persons With PD-MCINot yet recruitingNCT07411365Not applicable
- Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's DiseaseRecruitingNCT07151378Phase 3
- Prevent Cognitive Decline in GBA-associated Parkinson's DiseaseRecruitingNCT07055087Phase 2
- Progression in Cognitive ADLs in Parkinson's DiseaseStatus unknownNCT05806866
- DESENSITIZE-PD: Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Support Dopaminergic Desensitization in PDStatus unknownNCT05579379
- Cognitive-driven ADL Impairment as a Predictor for PDDCompletedNCT03687203
- Subthalamic Steering for Therapy Optimization in Parkinson's DiseaseCompletedNCT03548506Not applicable
- Combined Stimulation of STN and SNr for Dysphagia in Parkinson's DiseaseStatus unknownNCT03470324Not applicable
- Combined Stimulation of STN and SNr for Resistant Freezing of Gait in Parkinson's DiseaseStatus unknownNCT02588144Not applicable
- Combined STN/SNr-DBS for the Treatment of Refractory Gait Disorders in Parkinson's DiseaseCompletedNCT01355835Phase 2